ArticleAnnals of surgical oncology2025

Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Daisuke Hashimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.